Fraunhofer Institute for Digital Medicine MEVIS - Location Aachen



The Fraunhofer Institute for Digital Medicine MEVIS aims to detect diseases earlier and more reliably, to tailor treatments to individual patients, and to make therapeutic success measurable.

MEVIS pursues this goal by developing practical software systems for image- and data-based early detection, diagnosis and therapy with a strong network of clinical and academic partners. The focus is on cancer as well as diseases of the cardiovascular system, brain, breast, liver and lung.

In addition, the institute develops software systems for industrial partners to undertake image-based studies to determine the effectiveness of medicine and contrast agents. To reach its goals, Fraunhofer MEVIS works closely with medical technology and pharmaceutical companies, providing solutions for the entire chain of development from applied research to certified medical products.

Fraunhofer MEVIS’s interdisciplinary focus incorporates medicine, science, and industry, reflecting the institute’s operating principles and organizational structure. Researchers are not bound to strict, hierarchically organized work groups; they function in a flexible work environment that consists of medically defined domains and technologically oriented focuses which together dynamically adapt to the demands of research and development. This form of collaboration promotes cooperation between researchers for current projects and facilitates putting synergies into practice. This fosters the exchange of application-specific expertise and allows researchers to introduce their own multidisciplinary expertise for the benefit of the institute as a whole.

Through ten professorships, MEVIS is connected with seven universities in Germany, and the Netherlands – with the University of Bremen (Prof. Günther), the Jacobs University Bremen (Prof. Hahn, Prof. Preusser), the University of Applied Sciences Bremerhaven (Prof. Rascher-Friesenhausen), the University of Lübeck (Prof. Modersitzki), the Technical University of Berlin (Prof. Hennemuth), the RWTH Aachen (Prof. Kiessling, Prof. Merhof, Prof. Schulz), and the Radboud University Nijmegen (Prof. van Ginneken).